Development of CL184 Human Monoclonal Antibody Combination for Rabies Post-Exposure Prophylaxis, from Preclinical Design to Clinical Evaluation. Rev. Educ. Cont. Med. Vet. Zootec. 2013, 10 (2/3), 45-45.